Advertisement
Heart, Lung and Circulation
Letter to the Editor| Volume 29, ISSUE 9, e253, September 2020

Letter to the Editor regarding “Pathoanatomic Findings and Treatment During Hypertrophic Obstructive Cardiomyopathy Surgery: The Role of Mitral Valve” by Raffa et al., Heart Lung Circ, 2019;28:477-85

Published:April 14, 2020DOI:https://doi.org/10.1016/j.hlc.2020.03.015
      Congratulations to Raffa et al. on their study [
      • Raffa G.M.
      • Romano G.
      • Turrisi M.
      • Morsolini M.
      • Gentile G.
      • Sciacca S.
      • et al.
      Pathoanatomic findings and treatment during hypertrophic obstructive cardiomyopathy surgery: the role of mitral valve.
      ]. We wish to highlight some issues regarding their paper. The pathophysiological mechanism of the development of mitral regurgitation differs between hypertension and hypertrophic obstructive cardiomyopathy (HOCM). In HOCM, interventricular septum (IVS) and the anterior leaflet of the mitral valve approach each other owing to hypertrophy of IVS. Thus, the jet-like flow through the left ventricular outflow tract (LVOT) causes the Venturi effect and drags the anterior leaflet, leading to mitral regurgitation, which is called systolic anterior motion (SAM). In their paper, the authors stated that secondary chordae tendineae tractioning the anterior leaflet to IVS and SAM was seen in 22 cases (78%). What the cause of mitral regurgitation was in the remaining 22% is unclear. In Table 1, IVS thickness was only measured preoperatively. It may have been better to also measure the postoperative IVS thickness. Pathological examination, pre- and postoperative pressure gradients through the LVOT, and the remaining degree of mitral regurgitation after surgery would add to the scientific value of the paper.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Raffa G.M.
        • Romano G.
        • Turrisi M.
        • Morsolini M.
        • Gentile G.
        • Sciacca S.
        • et al.
        Pathoanatomic findings and treatment during hypertrophic obstructive cardiomyopathy surgery: the role of mitral valve.
        Heart Lung Circ. 2019; 28: 477-485